NDMA in Ranitidine: Understanding the Controversy and Taj Pharma’s Response
Ranitidine is commonly prescribed medicine for countering acidity holds a significant place on the WHO’s Model List of Essential Medicines. However, it found itself at the center of a raging controversy due to the presence of NDMA or N-Nitrosodimethylamine—a probable cancer-causing substance. Let’s delve into the controversy and Taj Pharmaceuticals’…